CA1039275A - 2-hydroxy-w-aminoalkyl-derivatives of aminoglycoside antibiotics - Google Patents

2-hydroxy-w-aminoalkyl-derivatives of aminoglycoside antibiotics

Info

Publication number
CA1039275A
CA1039275A CA238,246A CA238246A CA1039275A CA 1039275 A CA1039275 A CA 1039275A CA 238246 A CA238246 A CA 238246A CA 1039275 A CA1039275 A CA 1039275A
Authority
CA
Canada
Prior art keywords
amino
hydroxy
kanamycin
formula
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA238,246A
Other languages
English (en)
French (fr)
Inventor
James W. Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Application granted granted Critical
Publication of CA1039275A publication Critical patent/CA1039275A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA238,246A 1974-10-26 1975-10-24 2-hydroxy-w-aminoalkyl-derivatives of aminoglycoside antibiotics Expired CA1039275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4641274A GB1464401A (en) 1974-10-26 1974-10-26 Aminoglycosides

Publications (1)

Publication Number Publication Date
CA1039275A true CA1039275A (en) 1978-09-26

Family

ID=10441164

Family Applications (1)

Application Number Title Priority Date Filing Date
CA238,246A Expired CA1039275A (en) 1974-10-26 1975-10-24 2-hydroxy-w-aminoalkyl-derivatives of aminoglycoside antibiotics

Country Status (28)

Country Link
JP (1) JPS5519237B2 (da)
AR (1) AR205593A1 (da)
AT (1) AT340051B (da)
BE (1) BE834864A (da)
BG (1) BG24821A3 (da)
CA (1) CA1039275A (da)
CH (1) CH601339A5 (da)
CS (1) CS195712B2 (da)
DD (1) DD122522A5 (da)
DE (1) DE2547738C3 (da)
DK (1) DK147075C (da)
EG (1) EG11975A (da)
ES (1) ES442051A1 (da)
FI (1) FI752951A (da)
FR (1) FR2289202A1 (da)
GB (1) GB1464401A (da)
HU (1) HU172060B (da)
IE (1) IE42452B1 (da)
IL (1) IL48263A (da)
LU (1) LU73644A1 (da)
NL (1) NL162081C (da)
NZ (1) NZ179050A (da)
PH (1) PH12782A (da)
PL (1) PL99933B1 (da)
RO (1) RO72878A (da)
SE (1) SE7511945L (da)
SU (1) SU617017A3 (da)
ZA (1) ZA756326B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000473B1 (en) * 1977-06-24 1981-03-11 Scherico Ltd. Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives
JPS5488241A (en) * 1977-12-21 1979-07-13 Kyowa Hakko Kogyo Co Ltd Novel fortimicin a derivative
JPS57118475U (da) * 1981-01-14 1982-07-22

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606076A5 (da) * 1973-08-06 1978-10-13 Scherico Ltd

Also Published As

Publication number Publication date
AU8598175A (en) 1976-12-09
GB1464401A (en) 1977-02-16
FR2289202B1 (da) 1978-11-10
PL99933B1 (pl) 1978-08-31
DK481175A (da) 1976-04-27
ZA756326B (en) 1976-09-29
RO72878A (ro) 1983-07-07
DE2547738A1 (de) 1976-05-06
FR2289202A1 (fr) 1976-05-28
IL48263A0 (en) 1975-12-31
NL7512465A (nl) 1976-04-28
BG24821A3 (en) 1978-05-12
EG11975A (en) 1978-06-30
LU73644A1 (da) 1977-05-31
DD122522A5 (da) 1976-10-12
AT340051B (de) 1977-11-25
NL162081C (nl) 1980-04-15
CH601339A5 (da) 1978-07-14
DE2547738C3 (de) 1978-08-03
NL162081B (nl) 1979-11-15
BE834864A (fr) 1976-04-26
IE42452L (en) 1976-04-26
JPS5168543A (da) 1976-06-14
FI752951A (da) 1976-04-27
JPS5519237B2 (da) 1980-05-24
IE42452B1 (en) 1980-08-13
HU172060B (hu) 1978-05-28
PH12782A (en) 1979-08-17
ATA809575A (de) 1977-03-15
DK147075C (da) 1984-11-05
SE7511945L (sv) 1976-04-27
ES442051A1 (es) 1977-04-01
DK147075B (da) 1984-04-02
CS195712B2 (en) 1980-02-29
DE2547738B2 (de) 1977-12-01
SU617017A3 (ru) 1978-07-25
AR205593A1 (es) 1976-05-14
IL48263A (en) 1978-03-10
RO72878B (ro) 1983-06-30
NZ179050A (en) 1978-03-06

Similar Documents

Publication Publication Date Title
US3940382A (en) 1,2'-Di-N-substituted kanamycin B compounds
US4001208A (en) 1-N-[(S)-α-hydroxy-ω-aminoacyl]
EP0002835A1 (en) Aminoglycoside derivatives, process for their manufacture and pharmaceutical compositions
US3997524A (en) Process for the manufacture of 6'-N-alkyl derivatives of sisomicin and verdamicin; novel intermediates useful therein, and novel 6'-N-alkylverdamicins prepared thereby
US4107424A (en) 1-N-[(S)-α-hydroxy-ω-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics
CA1129852A (en) Aminoglycoside derivatives
US4214074A (en) Hydroxyalkyl derivatives of aminoglycoside antibiotics
US3784541A (en) Polyamine compounds and methods for their production
CA1039275A (en) 2-hydroxy-w-aminoalkyl-derivatives of aminoglycoside antibiotics
US4104372A (en) 1-N-(α-hydroxy-ω-aminoalkanoyl) derivatives of 3'-deoxykanamycin A and the production thereof
US4251516A (en) 2-Deoxy-3-O-Demethylfortimicins
US4283529A (en) 3-O-Demethyl derivatives of Sannamycin C and antibiotic AX-127B-1
US3939143A (en) 1-N-isoserylkanamycins and the production thereof
US4330673A (en) Process for producing 3-O-demethylaminoglycoside and novel 3-O-demethylfortimicin derivatives
US4217446A (en) ωAmino-2-hydroxyalkyl derivatives of aminoglycoside antibiotics
US4140849A (en) Kanamycin C derivatives
CA1050975A (en) 2-HYDROXY-.omega.-AMINOALKYL-DERIVATIVES OF AMINOGLYCOSIDE ANTIBIOTICS
US4205070A (en) 6'N-Alkyl- and 6',6'-di-N-alkyl derivatives of fortimicins A and B
KR790001020B1 (ko) 항균물질인 2-데옥시 스트렙타민-아미노 배당체류의 제조방법
US4282211A (en) 1-Epi-2-deoxyfortimicin B and derivatives
KR790001305B1 (ko) 2-데옥시스트랲트아민아미노그리코시드류의제조방법
US4108724A (en) Method for preparing antibiotic P-2563 using Pseudomonas fluorescens
US4331804A (en) 2-Epi-fortimicin A and derivatives
US4147861A (en) 1N-(α-Hydroxy-ω-aminoalkanoyl)-6'N-methyl-3',4'-dideoxykanamycin B and the production thereof
US4214080A (en) Fortimicins AM and AP